Obeticholic Acid and Edaravone Protect Against Cisplatin-Induced Hepatotoxicity Through Modulation of Keap1/Nrf2/ARE, TNF-α/NF-κB, and AKT/GSK-3β Pathways.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

publicrestrictedorigin: hub

Last updated 9/4/2026, 12:24:14 AM

Cite this record

African DSI DataBank. Obeticholic Acid and Edaravone Protect Against Cisplatin-Induced Hepatotoxicity Through Modulation of Keap1/Nrf2/ARE, TNF-α/NF-κB, and AKT/GSK-3β Pathways.. AFDSI-PUB-942. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-942 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42687554/.

BibTeX

@misc{AFDSIPUB942,
  title        = {Obeticholic Acid and Edaravone Protect Against Cisplatin-Induced Hepatotoxicity Through Modulation of Keap1/Nrf2/ARE, TNF-α/NF-κB, and AKT/GSK-3β Pathways.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-942}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-942; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42687554/}
}

AFDSI-PUB-942 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.